Advertisement
U.S. markets closed

PURE Bioscience, Inc. (PURE)

OTC Markets OTCPK - OTC Markets OTCPK Delayed Price. Currency in USD
0.1600+0.0050 (+3.23%)
At close: 01:24PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close0.1550
Open0.1600
Bid0.1500 x 0
Ask0.1600 x 0
Day's Range0.1600 - 0.1600
52 Week Range0.0600 - 0.1700
Volume10,000
Avg. Volume25,168
Market Cap17.897M
Beta (5Y Monthly)0.04
PE Ratio (TTM)N/A
EPS (TTM)-0.0300
Earnings DateDec 12, 2024 - Dec 16, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Business Wire

    PURE Bioscience Announces Distribution Agreement with Quip Laboratories

    EL CAJON, Calif., November 01, 2024--PURE Bioscience, Inc. (OTCQB: PURE) ("PURE," the "Company" or "we"), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, and Quip Laboratories, Inc. ("Quip Labs"), have entered into a multi-year distribution agreement for the purchase and selling of SDC products under special terms and conditions.

  • Business Wire

    PURE Bioscience Reports Fiscal 2024 Financial Results

    EL CAJON, Calif., October 29, 2024--PURE Bioscience, Inc. (OTCQB: PURE) ("PURE," the "Company" or "we"), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for the fiscal year ended July 31, 2024.